{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:25:37Z","timestamp":1795019137399,"version":"4.10.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019717","name":"AstraZeneca Pharmaceutical Spain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.semerg.2026.102813","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:10:49Z","timestamp":1784833849000},"page":"102813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CaReMe en atenci\u00f3n primaria: estrategias integrales para el manejo del paciente cardio-renal-metab\u00f3lico"],"prefix":"10.1016","volume":"52","author":[{"given":"M.I.","family":"Egocheaga Cabello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Alonso \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Castillo Moraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Cebri\u00e1n-Cuenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cols Sagarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Drak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Garc\u00eda Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Obaya Rebollar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ad\u00e1n Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2026.102813_bib0260","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","article-title":"The cardio-renal-metabolic connection: a review of the evidence","volume":"22","author":"Marassi","year":"2023","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.semerg.2026.102813_bib0265","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation."},{"key":"10.1016\/j.semerg.2026.102813_bib0270","author":"Ndumele","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.semerg.2026.102813_bib0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.102344","article-title":"Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review","volume":"49","author":"Sebastian","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.semerg.2026.102813_bib0280","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.nefro.2024.05.001","article-title":"La definici\u00f3n del s\u00edndrome cardiovascular-reno-metab\u00f3lico (cardiovascular-kidney-metabolic syndrome) y su papel en la prevenci\u00f3n, estatificaci\u00f3n del riesgo y tratamiento. Una oportunidad para la Nefrolog\u00eda","volume":"44","author":"Cases","year":"2024","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.semerg.2026.102813_bib0285","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.jacc.2024.03.368","article-title":"Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States","volume":"83","author":"Minhas","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semerg.2026.102813_bib0290","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nefro.2018.04.004","article-title":"Prevalencia de enfermedad renal cr\u00f3nica en Espa\u00f1a: impacto de la acumulaci\u00f3n de factores de riesgo cardiovascular","volume":"38","author":"Gorostidi","year":"2018","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.semerg.2026.102813_bib0295","first-page":"212","article-title":"Obesidad y enfermedad cardiovascular y renal. Posicionamiento de las Asociaciones de Cardiolog\u00eda Preventiva, Cardiolog\u00eda Cl\u00ednica e Insuficiencia Cardiaca de la SEC","volume":"59","author":"Castro Conde","year":"2024","journal-title":"REC: CardioClinics"},{"key":"10.1016\/j.semerg.2026.102813_bib0300","doi-asserted-by":"crossref","first-page":"101711","DOI":"10.1016\/j.cegh.2024.101711","article-title":"Early referral in chronic kidney disease\u2014seizing the opportunity","volume":"28","author":"Chogtu","year":"2024","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.semerg.2026.102813_bib0305","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1080\/00325481.2023.2256209","article-title":"Cardiorenal care coordination: Holistic patient care opportunities in the primary care setting for patients with chronic kidney disease and atherosclerotic cardiovascular disease","volume":"135","author":"Miller","year":"2023","journal-title":"Postgrad Med"},{"key":"10.1016\/j.semerg.2026.102813_bib0310","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.semerg.2026.102813_bib0315","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.semerg.2026.102813_bib0320","series-title":"Obesity and Lipotoxicity","first-page":"297","article-title":"Reappraisal of Adipose Tissue Inflammation in Obesity","author":"Engin","year":"2024"},{"key":"10.1016\/j.semerg.2026.102813_bib0325","article-title":"The association between visceral adiposity index and chronic kidney disease in the elderly: A cross-sectional analysis of NHANES 2011-2018","volume":"35","author":"Peng","year":"2023","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.semerg.2026.102813_bib0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.100987","article-title":"Onboarding obesity management in cardiovascular care: A cardiologist's guide to latest advances","volume":"22","author":"Schiele","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.semerg.2026.102813_bib0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117546","article-title":"Adiposity, type 2 diabetes and atherosclerotic cardiovascular disease risk: Use and abuse of the body mass index","volume":"394","author":"Arsenault","year":"2024","journal-title":"Atherosclerosis"},{"issue":"Suppl 4","key":"10.1016\/j.semerg.2026.102813_bib0340","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.semerg.2026.102813_bib0345","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semerg.2026.102813_bib0350","article-title":"Recomendaciones Hiperkalemia. Manejo en el paciente cardiorrenal","author":"Arranz-Mart\u00ednez","year":"2025","journal-title":"Semergen"},{"key":"10.1016\/j.semerg.2026.102813_bib0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100456","article-title":"Advanced subclinical atherosclerosis: A novel category within the cardiovascular risk continuum with distinct treatment implications","volume":"13","author":"Blaha","year":"2023","journal-title":"Am J Prev Cardiol"},{"issue":"Suppl 3","key":"10.1016\/j.semerg.2026.102813_bib0360","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2022.12.001","article-title":"US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States","volume":"81","author":"Johansen","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semerg.2026.102813_bib0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118585","article-title":"Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality","volume":"397","author":"Li","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semerg.2026.102813_bib0370","first-page":"195","article-title":"Detecci\u00f3n de aterosclerosis subcl\u00ednica mediante ecograf\u00eda vascular como m\u00e9todo de evaluaci\u00f3n de riesgo vascular. Protocolo simplificado","volume":"36","author":"Fr\u00edas Vargas","year":"2024","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.semerg.2026.102813_bib0375","first-page":"133","article-title":"SEA 2024 Standards for Global Control of Vascular Risk","volume":"36","author":"Mostaza","year":"2024","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.semerg.2026.102813_bib0380","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semerg.2026.102813_bib0385","unstructured":"SEMERGEN. Manejo pr\u00e1ctico del paciente con DM2 en atenci\u00f3n primaria 2024. [consultado 11 Oct 2025]. Disponible en: https:\/\/semergen.es\/files\/docs\/biblioteca\/guias\/2024\/guiasClinicasDiabetes2024.pdf"},{"key":"10.1016\/j.semerg.2026.102813_bib0390","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semerg.2026.102813_bib0395","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa2410659","article-title":"Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes","volume":"393","author":"Agarwal","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semerg.2026.102813_bib0400","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s12325-023-02482-5","article-title":"Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study","volume":"40","author":"Tangri","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.semerg.2026.102813_bib0405","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.pcd.2024.06.006","article-title":"Prevalence and characteristics of chronic kidney disease in people with type 2 diabetes mellitus in the Autonomous Community of Aragon","volume":"18","author":"Sanchez-Calavera","year":"2024","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.semerg.2026.102813_bib0410","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1161\/CIR.0000000000001031","article-title":"2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association","volume":"144","author":"Lichtenstein","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.semerg.2026.102813_bib0415","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/eurheartj\/ehad853","article-title":"Ten tips for promoting cardiometabolic health and slowing cardiovascular aging","volume":"45","author":"Cagigas","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semerg.2026.102813_bib0420","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fcvm.2019.00069","article-title":"Effects of Exercise to Improve Cardiovascular Health","volume":"6","author":"Pinckard","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.semerg.2026.102813_bib0425","unstructured":"WHO. Physical Activity 2026. [consultado 20 Ene 2026]. Disponible en: https:\/\/www.who.int\/initiatives\/behealthy\/physical-activity"},{"key":"10.1016\/j.semerg.2026.102813_bib0430","article-title":"Low cigarette consumption and risk of coronary heart disease and stroke: Meta-analysis of 141 cohort studies in 55 study reports","volume":"360","author":"Hackshaw","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.semerg.2026.102813_bib0435","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11886-017-0916-0","article-title":"Sleep and Cardio-Metabolic Disease","volume":"19","author":"Cappuccio","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.semerg.2026.102813_bib0440","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1161\/CIR.0000000000000947","article-title":"Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association","volume":"143","author":"Levine","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.semerg.2026.102813_bib0445","article-title":"SEMERGEN position paper on chronic kidney disease [Article in Spanish]","volume":"52","author":"Perez-Leon","year":"2026","journal-title":"Semergen"},{"issue":"Suppl 5","key":"10.1016\/j.semerg.2026.102813_bib0450","first-page":"S1","article-title":"KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.semerg.2026.102813_bib0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100851","article-title":"SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health","volume":"6","author":"Madero","year":"2024","journal-title":"Kidney Med"},{"key":"10.1016\/j.semerg.2026.102813_bib0460","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semerg.2026.102813_bib0465","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12933-021-01366-8","article-title":"GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: An updated meta-analysis of eight CVOTs","volume":"20","author":"Giugliano","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.semerg.2026.102813_bib0470","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/metabo14050264","article-title":"Ketoacidosis and SGLT2 Inhibitors: A Narrative Review","volume":"14","author":"Morace","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.semerg.2026.102813_bib0475","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/anae.16541","volume":"80","author":"El-Boghdadly","year":"2025","journal-title":"Anaesthesia"},{"key":"10.1016\/j.semerg.2026.102813_bib0480","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semerg.2026.102813_bib0485","author":"Garc\u00eda-Soid\u00e1n","year":"2026","journal-title":"Algoritmo de tratamiento de la DM2, de la redGDPS"},{"key":"10.1016\/j.semerg.2026.102813_bib0490","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semerg.2026.102813_bib0495","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semerg.2026.102813_bib0500","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in Patients with Chronic Kidney Disease","volume":"388","author":"The E-KCG","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semerg.2026.102813_bib0505","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326001309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326001309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:15:02Z","timestamp":1795018502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359326001309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1138359326001309"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102813","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CaReMe en atenci\u00f3n primaria: estrategias integrales para el manejo del paciente cardio-renal-metab\u00f3lico","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN).","name":"copyright","label":"Copyright"}],"article-number":"102813"}}